Navigation Links
MedApps Receives Prestigious Frost & Sullivan Award
Date:2/6/2008

SCOTTSDALE, Ariz., Feb. 6 /PRNewswire/ -- MedApps announced today that it is the proud recipient of the 2008 Frost & Sullivan North American Technology Innovation Award in the field of Wireless Point of Care.

Frost & Sullivan's Technology Innovation Award is bestowed upon a company (or individual) that has carried out new research, which has resulted in innovation(s) that have or are expected to bring significant contributions to the industry in terms of adoption, change, and competitive posture. This award recognizes the quality and depth of a company's research and development program as well as the vision and risk-taking that enabled it to undertake such an endeavor.

"Frost & Sullivan does not accept nominations or submissions for their Awards," said Jeff Frigstad, Global Director of Frost & Sullivan's Best Practices Awards division. "The selection of this Award comes through in-depth interviews and primary market analysis conducted by our industry analyst team."

MedApps has been recognized for its unique technologies (Body Area Network and BluePAL(TM)) forming the backbone of its Telemedicine 2.0 concept. Telemedicine 2.0 as compared to the wired technology of Telemedicine 1.0 is a wireless technology, which is designed to help those patients who suffer from one or more chronic diseases such as diabetes, congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), asthma or other diseases. This new technology can help healthcare professionals monitor and react to changes in a patient's medical condition as they occur. The company's dedication toward developing this novel real-time telemedicine technology platform employing individual techniques such as Body Area Network and BluePAL(TM) has attracted considerable industry interest as the nature of commercial remote glucose monitoring still remains adynamic.

"As a team, we are very proud of receiving this award," said Kent Dicks, President / CEO of MedApps. "To be recognized by Frost & Sullivan, a leading authority in industry / market trends, is extremely satisfying knowing that we are on the right track, with the right vision, at the right point in time."

About Frost & Sullivan

Frost & Sullivan, the Global Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnerships, visit http://www.awards.frost.com.

About MedApps

MedApps, headquartered in Scottsdale, Arizona, is a new and emerging leader in Mobile Wireless Health Monitoring -- designed to connect people with their healthcare providers, in a timely and cost effective manner. MedApps was named to the Fierce Health IT Top 10 Healthcare IT Innovators for 2007 (http://www.fiercehealthit.com/innovators/2007/medapps) and was nominated for the Governors Celebration of Innovation - Startup for 2007 (http://www.celebration-of-innovation.com/news.aspx).

http://www.medapps.net

Media Contact:

Randy Strength

MedApps, Inc.

(480) 686-5676

randy.strength@medapps.net


'/>"/>
SOURCE MedApps, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. IDM Pharma Receives Notification from NASDAQ Relating to Minimum Bid Price
2. Ludwig Institute for Cancer Research receives NHMRCs largest 2009 grant
3. Jacobs Receives Contract from Catholic Healthcare West to Assist Sequoia Hospital Expansion Program
4. Akela Pharma receives letter from the FDA regarding its pre-clinical toxicology studies for Fentanyl TAIFUN(R)
5. Regions Hospital Receives National Quality Awards
6. Laser Energetics Receives a $550,000 Order for a Dental Laser System
7. China Pharma Holdings, Inc. Receives Chinese SFDA Approval for Generic Bumetanide Injection
8. Abbotts Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA
9. Disabled Sacramento Woman, 110, Receives Power Wheelchair Donation from The SCOOTER Store
10. AutoGenomics Receives FDA Clearance for its INFINITI(TM) Warfarin Assay
11. Siemens Receives FDA 510(K) Clearance for Next Generation Radiation Therapy Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... Adding to ... England Journal of Medicine and NEJM Journal Watch, announces the release of ... created by a panel of pediatricians from leading medical centers. The content was ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... The comprehensive weight management program at Women’s Excellence will help patients lose weight ... and physical exam. The specialists at Women's Excellence will measure BMI, body ...
(Date:3/27/2017)... ... ... Janet Schloz is still in shock after receiving a $2,500 Academic Award from California ... she said. , She thinks the coming week is going to be a very joyful ... to help my students.” , The award will allow the 4th grade teacher at Tumwater ...
(Date:3/27/2017)... ... 2017 , ... ?Grow Healthy Vending LLC announced today that ... itself and 1800 Vending DBA Healthy You Vending. (Civil No. 1:14-CV-00121-CW/ United States ... that we have now reached a settlement agreement regarding the ongoing lawsuits between ...
(Date:3/26/2017)... ... March 26, 2017 , ... Local physician ... 100 Award, a prestigious award honoring the top influencers on RealSelf—the most trusted ... connect with doctors and clinics. , In 2016, more than 82 million people ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Israel , March 27, 2017 ... oncology and immunology, announced today that AGI-134, an immunotherapy for ... acquisition of Agalimmune Ltd., will be featured at the upcoming ... in Washington, DC to be held ... ...
(Date:3/27/2017)... The staggering cost of cancer treatment means ... to the latest treatment options against cancer. Even among ... have inadequate or no health insurance and are oftentimes ... to modern cancer treatment is almost non-existent for cancer ... The mission statements of pharmaceutical and biotech companies often ...
(Date:3/27/2017)... , March 27, 2017 ... as the NASDAQ Composite closed the trading session up ... and the S&P 500 was down 0.08%. US markets ... sectors finishing the day in green. Pre-market today, Stock-Callers.com ... Medical Group N.V. (NASDAQ: WMGI), Amedica Corporation (NASDAQ: AMDA), ...
Breaking Medicine Technology: